ISA to Present at the 4th Annual Virtual H.C. Wainwright HBV Conference on October 25th

First Patient with Chronic Hepatitis B Dosed with ISA104 in First-in-Human Phase 1 Study

Professor Melief to receive 2022 SITC Pedro J. Romero Award

ISA has relocated to brand new Biopartner 5 building

ISA Pharmaceuticals to present at the Virtual European Biotech Investor Day 2020

ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration with Regeneron

ISA in the news: MedNous’ article on CervISA

ISA Pharmaceuticals B.V. receives EUR 20m loan from European Investment Bank